Inner Mongolia People's Hospital Successfully Performed the Third-generation FCVB Surgery

On March 3, Inner Mongolia People's Hospital successfully carried out the third-generation Foldable Capsular Vitreous Body (FCVB) surgery. Professor Gerelt successfully implanted the product for a patient with silicone oil-dependent eye, preserving hope. FCVB is a new and advanced technology for eye preservation, offering a novel treatment approach for patients with severe retinal detachment, ocular trauma, and silicone oil-dependent eyes, which is of great significance for saving the patients' eyeballs.

Overview of the Illness Condition
The patient is a 67-year-old male. His visual acuity dropped sharply after his right eye was injured by a snowplow on December 11, 2023, and he was admitted to the Ophthalmology Department of Inner Mongolia People's Hospital for treatment. During his hospitalization, Professor Gerelt performed surgeries such as "right eye conjunctival suture + scleral exploration + conjunctival sac irrigation", "phacoemulsification aspiration of right eye cataract + vitrectomy + air-fluid exchange + silicone oil implantation + anterior chamber irrigation" on him. The patient recovered well after the surgery and had regular follow-up examinations. Recently, the patient was admitted to the hospital again for further diagnosis and treatment with the condition of "silicone oil filling state after vitrectomy of the right eye".
 

The team led by Professor Gerelt examined him and found that the visual acuity of his right eye was in the state of blackout, and the intraocular pressure of the right eye was 10mmHg.

Considering the disadvantages of silicone oil-dependent eyes and the patient and his family's unwillingness for repeated surgeries, Professor Gerelt suggested that the patient could undergo the third-generation Foldable Capsular Vitreous Body (FCVB) surgery and invited Professor Gao Qianying, the developer of the product, to assist.
 

On the morning of March 3, the team led by Professor Gerelt and Professor Gao jointly performed the third-generation FCVB surgery on the patient. The folded capsule was implanted into the eye through a minimally invasive incision, and then silicone oil was injected into the bcapsule through the drainage valve to support the retina and maintain the intraocular pressure. Finally, the third-generation FCVB was successfully implanted into the patient's eye.
 

During the postoperative review, it was found that the position of the capsule in the right eye was normal, the intraocular pressure was normal, the anterior chamber was deep, and the cornea was transparent. The patient was satisfied with the postoperative effect and expressed sincere gratitude to the doctors!